Tectonic Therapeutic, Inc. logo TECX - Tectonic Therapeutic, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 4
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $72.00 DETAILS
HIGH: $81.00
LOW: $60.00
MEDIAN: $75.00
CONSENSUS: $72.00
UPSIDE: 89.82%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue
Revenue 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 0 0 0 0 0 1.2 0.8 0.4 0.0 0
Gross Profit 0 0 0 0 0 (1.2) (0.8) (0.4) (0.0) 0
Operating Expenses
R&D Expenses 63.5 41.4 37.0 25.7 11.0 86.0 55.0 35.1 15.2 2.7
SG&A Expenses 20.5 16.7 7.7 7.2 4.6 33.0 20.0 10.8 3.1 2.0
Other Expenses 0 0 0 0 0 0 0 0 0 0
Operating Expenses 84.0 58.0 44.6 32.8 15.6 119.0 75.0 45.9 18.3 4.6
Operating Income
Operating Income (84.0) (58.0) (44.6) (32.8) (15.6) (120.2) (75.8) (46.2) (18.4) (4.6)
Interest Expense 0.1 0.1 0.2 0.1 0.2 0 0 0 0 0
Interest Income 11.3 4.3 0.6 0.1 0 0.7 2.9 1.7 0.1 0.0
Profitability
EBITDA (71.5) (56.2) (41.2) (31.0) (8.1) (118.5) (72.1) (46.0) (18.6) (4.7)
EBIT (72.9) (57.9) (42.7) (32.0) (8.5) (119.7) (73.0) (46.4) (18.6) (4.7)
Income Before Tax (72.9) (58.0) (42.8) (32.2) (8.9) (119.7) (73.0) (46.4) (18.6) (4.7)
Income Tax Expense 1.2 0 0 0 0 0 0 0 0 0
Net Income (74.2) (58.0) (42.8) (32.2) (8.9) (119.7) (73.0) (46.4) (18.6) (4.7)
Per Share Data
EPS (Basic) -4.05 -3.93 -11.59 -29.05 -33.36 -39.68 -31.92 -23.41 -9.35 -2.34
EPS (Diluted) -4.05 -3.93 -11.53 -29.05 -33.36 -39.68 -31.92 -23.41 -9.35 -2.34
Shares Outstanding 18.3 14.8 3.7 3.6 3.6 3.0 2.3 2.0 2.0 2.0
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Current Assets
Cash & Cash Equivalents 253.8 141.2 28.8 36.0 28.1 259.7 187.0 126.3 6.0 5.4
Short-Term Investments 0 0 0 0 0 0 0 0 0 0
Net Receivables 0 0 0 0 0 2.6 2.1 1.5 0 0
Inventory 0 0 0 0 0 0 0 0 0 0
Other Current Assets 3.6 5.6 2.1 1.1 0.6 0.3 0.6 0.8 0.1 0.0
Total Current Assets 257.4 146.9 30.9 37.0 28.6 267.2 195.7 130.0 6.3 5.4
Non-Current Assets
Property, Plant & Equipment 2.6 5.3 7.2 9.6 3.7 3.1 3.7 2.6 0.3 0
Goodwill 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0.6 0 0 0 0.5 0.5 0.5 0.0 0.0
Other Non-Current Assets 1.1 0.2 1.3 0.6 0.6 0.4 0.6 0.3 0.3 0
Total Non-Current Assets 3.7 6.0 8.5 10.2 4.3 4.0 4.8 3.5 0.7 0.0
Total Assets 261.0 152.9 39.4 47.2 32.9 271.2 200.5 133.5 7.0 5.4
Current Liabilities
Account Payables 1.1 1.0 0.4 0.6 1.8 2.7 3.9 2.8 0.5 0.3
Short-Term Debt 0 0 0 0 0 0 0 0 0 0
Deferred Revenue 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 4.1 3.6 33.4 2.7 1.8 7.5 7.0 5.2 1.3 0.2
Total Current Liabilities 9.7 11.6 40.9 7.8 4.1 16.6 14.0 10.6 2.6 0.9
Non-Current Liabilities
Long-Term Debt 0.0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 80.6 80.7 43.0 0.3 0.5 0.7 1.0 0.1
Total Non-Current Liabilities 0.0 0.5 83.1 85.0 43.7 0.3 0.5 0.7 1.0 0.1
Total Liabilities 9.7 12.1 124.0 92.9 47.8 16.9 14.5 11.3 3.7 1.0
Stockholders' Equity
Common Stock 0.0 0.0 0 0 0 0.0 0.0 0.0 0.0 0.0
Retained Earnings (222.7) (148.6) (90.6) (47.8) (15.6) (264.4) (144.7) (71.7) (23.5) (4.8)
Accumulated Other Comprehensive Income (0.1) 0.0 (0.0) 0 0 0 0 0 (0.0) (0.0)
Total Stockholders' Equity 251.3 140.8 (84.6) (45.7) (15.0) 254.3 186.0 122.2 3.4 4.4
Total Liabilities & Equity 261.0 152.9 39.4 47.2 32.9 271.2 200.5 133.5 7.0 5.4
Debt Metrics
Total Debt 1.3 3.3 4.3 5.8 1.1 0 0 0 0 0
Net Debt (252.5) (137.9) (24.4) (30.2) (27.0) (259.7) (187.0) (126.3) (6.0) (5.4)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Operating Activities
Net Income (74.2) (58.0) (42.8) (0.0) (8.9) (119.7) (73.0) (46.4) (18.6) (4.7)
Depreciation & Amortization 1.4 1.6 1.5 0.0 0.4 1.2 0.8 0.4 0.0 0
Stock-Based Compensation 10.5 3.5 1.1 0.0 0.6 0 0 0 0 0
Change in Working Capital (0.1) (10.3) (0.6) (7.4) 1.9 4.2 (2.2) 4.2 1.6 0.7
Other Non-Cash Items 2.3 4.0 0.1 (89.8) (6.4) 15.5 6.6 2.9 0.5 0.5
Operating Cash Flow (60.1) (59.1) (40.7) (97.2) (12.5) (98.8) (67.7) (37.6) (16.4) (3.3)
Investing Activities
Capital Expenditure (0.2) (0.2) (0.3) (0.3) (2.1) (1.2) (1.6) (1.8) (0.4) 0
Acquisitions 0.1 0 0 0 0 0 0 0 0 0
Purchases of Investments 0 0 0 0 0 0 0 0 0 (0.0)
Sales/Maturities of Investments 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 0 0 0 0 0
Investing Cash Flow (0.1) (0.2) (0.3) (0.3) (2.1) (1.2) (1.6) (1.8) (0.4) (0.0)
Financing Activities
Net Debt Issuance (0.5) (0.5) (0.5) (0.4) 3.6 0 0 0 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (0.5) 77.6 0.1 0.4 0 0 0 0 (0.0) 8.7
Financing Cash Flow 173.4 171.7 33.7 0.3 41.4 172.6 130.0 160.3 17.4 8.7
Cash Position
Net Change in Cash 113.0 112.5 (7.2) (96.7) 26.8 72.6 60.7 120.3 0.6 5.4
Cash at Beginning 141.8 29.4 36.6 189.6 1.8 187.0 126.3 6.0 5.4 0
Cash at End 254.9 141.8 29.4 92.8 28.6 259.7 187.0 126.3 6.0 5.4
Free Cash Flow (60.3) (59.2) (41.0) (97.5) (14.6) (100.0) (69.3) (39.5) (16.8) (3.3)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Income Statement
Revenue 0 0 0 0 0 0 0 0 0 0
Gross Profit 0 0 0 0 0 (1.2) (0.8) (0.4) (0.0) 0
Operating Income (84.0) (58.0) (44.6) (32.8) (15.6) (120.2) (75.8) (46.2) (18.4) (4.6)
Net Income (74.2) (58.0) (42.8) (32.2) (8.9) (119.7) (73.0) (46.4) (18.6) (4.7)
EPS (Diluted) -4.05 -3.93 -11.53 -29.05 -33.36 -39.68 -31.92 -23.41 -9.35 -2.34
Balance Sheet
Cash & Equivalents 253.8 141.2 28.8 36.0 28.1 259.7 187.0 126.3 6.0 5.4
Total Assets 261.0 152.9 39.4 47.2 32.9 271.2 200.5 133.5 7.0 5.4
Total Debt 1.3 3.3 4.3 5.8 1.1 0 0 0 0 0
Stockholders' Equity 251.3 140.8 (84.6) (45.7) (15.0) 254.3 186.0 122.2 3.4 4.4
Cash Flow
Operating Cash Flow (60.1) (59.1) (40.7) (97.2) (12.5) (98.8) (67.7) (37.6) (16.4) (3.3)
Capital Expenditure (0.2) (0.2) (0.3) (0.3) (2.1) (1.2) (1.6) (1.8) (0.4) 0
Free Cash Flow (60.3) (59.2) (41.0) (97.5) (14.6) (100.0) (69.3) (39.5) (16.8) (3.3)